140 related articles for article (PubMed ID: 32921983)
1. Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin.
Harahap Y; Ardiningsih P; Corintias Winarti A; Purwanto DJ
Drug Des Devel Ther; 2020; 14():3469-3475. PubMed ID: 32921983
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin, doxorubicinol, cardiotoxicity, breast cancer, volumetric absorptive microsampling, LC-MS/MS.
Chairunnisa DF; Harahap Y; Juanita M; Syafhan NF; Purwanto DJ
Pak J Biol Sci; 2024 Mar; 27(3):125-131. PubMed ID: 38686734
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of Doxorubicin Hydrochloride and Doxorubicinol Quantification Method in Dried Blood Spot by Liquid Chromatography-Tandem Mass Spectrometry.
Harahap Y; Suryadi H; Anarta A
J Pharm Bioallied Sci; 2020; 12(4):406-412. PubMed ID: 33679086
[TBL] [Abstract][Full Text] [Related]
4. Liquid Chromatography-Tandem Mass Spectrometry for the Simultaneous Determination of Doxorubicin and its Metabolites Doxorubicinol, Doxorubicinone, Doxorubicinolone, and 7-Deoxydoxorubicinone in Mouse Plasma.
Choi WG; Kim DK; Shin Y; Park R; Cho YY; Lee JY; Kang HC; Lee HS
Molecules; 2020 Mar; 25(5):. PubMed ID: 32164308
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous measurement of doxorubicin and reduced metabolite doxorubicinol by UHPLC-MS/MS in human plasma of HCC patients treated with TACE.
Sottani C; Poggi G; Melchiorre F; Montagna B; Minoia C
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 915-916():71-8. PubMed ID: 23337906
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?
Kunarajah K; Hennig S; Norris RLG; Lobb M; Charles BG; Pinkerton R; Moore AS
Cancer Chemother Pharmacol; 2017 Jul; 80(1):15-25. PubMed ID: 28444427
[TBL] [Abstract][Full Text] [Related]
7. Quantification of pegylated liposomal doxorubicin and doxorubicinol in rat plasma by liquid chromatography/electrospray tandem mass spectroscopy: Application to preclinical pharmacokinetic studies.
Liu Y; Yang Y; Liu X; Jiang T
Talanta; 2008 Jan; 74(4):887-95. PubMed ID: 18371724
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/MS method development for quantification of doxorubicin and its metabolite 13-hydroxy doxorubicin in mice biological matrices: Application to a pharmaco-delivery study.
Mazzucchelli S; Ravelli A; Gigli F; Minoli M; Corsi F; Ciuffreda P; Ottria R
Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27714830
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of four anthracyclines and three metabolites in human serum by liquid chromatography-electrospray mass spectrometry.
Lachâtre F; Marquet P; Ragot S; Gaulier JM; Cardot P; Dupuy JL
J Chromatogr B Biomed Sci Appl; 2000 Feb; 738(2):281-91. PubMed ID: 10718646
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients].
Wihlm J; Limacher JM; Levêque D; Duclos B; Dufour P; Bergerat JP; Methlin G
Bull Cancer; 1997 Jun; 84(6):603-8. PubMed ID: 9295863
[TBL] [Abstract][Full Text] [Related]
11. Validation and clinical evaluation of a UHPLC method with fluorescence detector for plasma quantification of doxorubicin and doxorubicinol in haematological patients.
Pérez-Blanco JS; Fernández de Gatta Mdel M; Hernández-Rivas JM; García Sánchez MJ; Sayalero Marinero ML; González López F
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 955-956():93-7. PubMed ID: 24631816
[TBL] [Abstract][Full Text] [Related]
12. Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography.
de Bruijn P; Verweij J; Loos WJ; Kolker HJ; Planting AS; Nooter K; Stoter G; Sparreboom A
Anal Biochem; 1999 Jan; 266(2):216-21. PubMed ID: 9888978
[TBL] [Abstract][Full Text] [Related]
13. Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography.
Chin DL; Lum BL; Sikic BI
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):259-69. PubMed ID: 12361740
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer.
Swenson CE; Bolcsak LE; Batist G; Guthrie TH; Tkaczuk KH; Boxenbaum H; Welles L; Chow SC; Bhamra R; Chaikin P
Anticancer Drugs; 2003 Mar; 14(3):239-46. PubMed ID: 12634619
[TBL] [Abstract][Full Text] [Related]
15. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: Estimation of doxorubicin hepatic extraction ratio.
Pippa LF; Oliveira ML; Rocha A; de Andrade JM; Lanchote VL
J Pharm Biomed Anal; 2020 Jun; 185():113231. PubMed ID: 32163849
[TBL] [Abstract][Full Text] [Related]
16. A pharmacokinetic and pharmacodynamic study of the new anthracycline pirarubicin in breast cancer patients.
Robert J; Monnier A; Poutignat N; Hérait P
Cancer Chemother Pharmacol; 1991; 29(1):75-9. PubMed ID: 1742853
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic modelling of acute N-terminal pro B-type natriuretic peptide after doxorubicin infusion in breast cancer.
Liang S; Brundage RC; Jacobson PA; Blaes A; Kirstein MN
Br J Clin Pharmacol; 2016 Sep; 82(3):773-83. PubMed ID: 27128712
[TBL] [Abstract][Full Text] [Related]
18. The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: insight to explain the cardiac safety of pixantrone in doxorubicin-treated patients.
Salvatorelli E; Menna P; Paz OG; Chello M; Covino E; Singer JW; Minotti G
J Pharmacol Exp Ther; 2013 Feb; 344(2):467-78. PubMed ID: 23192654
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous analysis of cyclophosphamide, doxorubicin and doxorubicinol by liquid chromatography coupled to tandem mass spectrometry.
DiFrancesco R; Griggs JJ; Donnelly J; DiCenzo R
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):545-53. PubMed ID: 17379584
[TBL] [Abstract][Full Text] [Related]
20. Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice.
Webster LK; Cosson EJ; Stokes KH; Millward MJ
Br J Cancer; 1996 Feb; 73(4):522-4. PubMed ID: 8595168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
